Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT05766748 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Cantex Pharmaceuticals |
| Last Updated on CT.gov | June 14, 2024 (Jun 14, 2024) |
As of March 2, 2026: Clinical trial NCT05766748 is currently recruiting participants. This clinical trial study for pancreatic cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Cantex Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05766748 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05766748 was last updated Jun 14, 2024 (June 14, 2024). HelloStudys verifies this status automatically.